Publications

Evaluating antivenom efficacy against Echis carinatus venoms-screening for in vitro alternatives.

Toxins

A comparative study of antibody response, virus neutralization efficiency & metabolites in SARS-CoV-2-infected adults & children

The Indian Journal of Medical Research

Glycolytic inhibitor 2-Deoxy-D-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions.

Life Sciences

Detection of SARS-CoV-2 in the air in Indian hospitals and houses of COVID-19 patients.

Journal of Aerosol Science.

SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells.

Microbiology Spectrum.

Equine immunoglobulin fragment F(ab)2 displays high neutralizing capability against multiple SARS-CoV-2 variants

Clinical Immunology

Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy

Front. Nanotechnol., 08 June 2022 | https://doi.org/10.3389/fnano.2022.911063

Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models.

Nanoscale. 2022 Jan 6;14(2):492-505. doi: 10.1039/d1nr04411g. PMID: 34913453.

Defensins: Attractive therapeutic molecules with potential to treat SARS-CoV-2 infection

Indian Journal of Medical Research

Down regulation of Defensin genes in SARS-CoV-2 infection.

Acta Virologica